A transcriptional enhancer required for the differential expression of the human estrogen receptor in breast cancers.
Breast cancers lacking estrogen receptor (ER) expression have an adverse prognosis and fail to respond to endocrine therapy. We have identified a transcriptional enhancer in the human ER gene which is differentially active in ER-positive (ER+) and ER-negative (ER-) human breast cancer cell lines. En...
Salvato in:
| Pubblicato in: | Mol Cell Biol |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Taylor & Francis
1997
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC231852/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9032254/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/mcb.17.3.1274 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
